Treatments

Brexpiprazole (Rexulti) for Alzheimer's agitation

Brexpiprazole became the first FDA-approved medication for Alzheimer's-related agitation in 2023. It's helpful for some — but it's a serious medication.

Updated 2026-02-20

Portrait of Ashlee Skabla Velez, APRN, ACNPC-AG
By Ashlee Skabla Velez, APRN, ACNPC-AG · Clinically reviewed

What it does

Brexpiprazole is an atypical antipsychotic that, in trials, reduced agitation scores in Alzheimer's. Effects are modest. Side effects are real.

Before reaching for it

  • Rule out infection, pain, and constipation.
  • Try environmental + behavioral interventions for several weeks.
  • Audit current medications for anticholinergic burden.
  • Discuss the boxed warning — increased mortality in older adults with dementia-related psychosis.

Frequently asked questions

Is Rexulti better than older antipsychotics like Risperdal?
It's the only one specifically FDA-approved for this use. Comparison studies are limited.

Every dementia journey is different.

Memory Lane Care helps you understand what applies to your loved one, what to expect next, and which resources fit your family's situation.

Related across the journey

Memory Lane connects every part of dementia care. Here's how this topic threads into the rest.

Keep reading

Made with Emergent